Endocrine disruptors (EDs) with androgenic and anti-androgenic effects may alter reproductive function by binding to androgenic receptors (AR) and inducing or modulating AR-dependent responses in the male reproductive system. However, the molecular mechanism(s) underlying these events remains unclear. In the present study, pregnant Sprague Dawley (SD) rats were treated with testosterone propionate (TP), flutamide (Flu) and di-(2ethylhexyl) phthalate (DEHP) from gestation days (GD) 11 to 21. Interestingly, maternal exposure to Flu or DEHP caused fluctuations in the neonatal levels of serum testosterone (T) and luteinizing hormone (LH). Serum testosterone and LH were upregulated by Flu, but these hormones were down-regulated by DEHP. The anogenital distances (AGD) of male newborns were determined at post-neonatal days (PND) 1, 21 and 63. Male rats treated prenatally with DEHP (100 mg/kg mother's body weight) or Flu showed an AGD shorter than that of control rats. At PND 63, sperm concentration, viability and motility were reduced in the maternal DEHP and Flu-treated groups. The numbers of seminiferous tubules were reduced in the Flu and DEHP-treated offspring when compared with the vehicle-and TPtreated groups, and the tubules of the testes at PND 63 were disrupted by a high dose of Flu. In addition, we found differential gene expression patterns by microarray analysis following ED exposure, particularly in sex determinationrelated genes. Although Flu and DEHP are considered to be identical with regard to their anti-androgenic effects, their effects on developing male reproductive organs were distinct, suggesting that Flu competes with endogenous T, while DEHP influences a different step in androgenesis.
(J. Reprod. Dev. 55: 400-411, 2009) ecently, environmental, anti-androgenic compounds have been recognized as endocrine disruptors (EDs) because of their hormone-like activities. Anti-androgenic chemicals have the potential to interfere with male reproductive development and function in humans and animals. The EDs are thought to act via many mechanisms, such as by decreasing androgen synthesis, exerting effects on the pituitary-gonadal axis and/or blocking the androgen receptor (AR) [1, 2] . The consequences of these actions may cause abnormal hormonal regulation and gene expression.
It has been demonstrated that the AR plays a critical role in control of male sexual differentiation. During mammalian sex differentiation, the androgens, testosterone (T) and its metabolite dihydrotestosterone (DHT), produced by the fetal/neonatal male during sexual differentiation are critical factors in the male phenotype [3] . Sex development continues postnatally with the onset of secondary sexual characteristics at puberty and the acquisition of reproductive capacity. In addition, the differentiation of the Wolffian structures (e.g., the epididymis, vas deferens and seminal vesicles) appears to be T-mediated, while masculinization of the prostate and external genitalia are controlled by the more potent androgen DHT. These developmental events may be influenced by ED-exposure via an AR-mediated mechanism in which the ED acts either as a hormone agonist or antagonist [4] .
A variety of chemicals present in the environment have the potential to interfere with the normal function of the endocrine system. While there is good agreement that these compounds may induce reproductive, developmental and behavioral changes at high doses in experimental animals, discussion still persists about whether their low doses may also contribute to induction of disorders in humans and wildlife [5, 6] . In fact, androgen deficiency caused by exposure to antiandrogens during critical stages of development results in various sexual aberrations in male animals, including a decrease in the anogenital distance (AGD), increase in nipple retention, underdevelopment or absence of reproductive organs, malformed external genitalia (hypospadia), undescended testes (cryoptorchidism) and decreased sperm concentration [7] .
Phthalates are well known as reproductive toxicants in mammals. The toxic effects of this ED class on the reproductive system have been observed in many previous studies. Furthermore, many previous reports have demonstrated the ability of these compounds to disrupt sexual differentiation of the male fetus [8, 9] . The spectrum of effects induced by prenatal exposure to activated phthalates like di(butyl) phthalate (DBP) and di-(2-ethylhexyl) phthalate (DEHP) are believed to arise from disruption of Sertoli cell and Leydig cell functions in the developing testis [10, 11] . The conse-quences of high dose, maternal phthalate exposure include reduced anogenital distance, retained nipples, undescended testis, hypospadias, small accessory sex glands and epididymal and testicular abnormalities, all of which have been observed in male offspring rats [4, 12] . A number of these reproductive tract anomalies are characteristic of disturbances in androgen-dependent development. In addition, disturbance of normal gonocyte development resulting in multinucleated cells and subsequent changes in testicular function (e.g., reduced sperm production) have been associated with abnormal Sertoli cell function and proliferation [10] .
Flutamide (Flu) is a non-steroidal antiandrogen that inhibits androgen uptake and/or nuclear binding of androgen in target tissues. This chemical is well known as a potent AR antagonist, having been widely used in studies of male reproductive development. It has been demonstrated that pre-and postnatal flutamide exposure of rats may alter androgen-dependent reproductive development and function [13] . Some investigators have reported adverse trends in male reproductive health, including an increasing incidence of testicular cancer [14] , low and probably declining semen quality and increasing incidences of cryoptorchidism, i.e., undescended testis, and hypospadias [7] . Both the increased incidence of testicular cancer and decreased sperm quality have shown a birth-cohort effect [15] , indicating that there are more problems in younger generations. Additionally, it has been proposed that all of these disorders have a common origin in fetal life, and thus, they all represent different symptoms of the same underlying entity called testicular dysgenesis syndrome (TDS) [16] . The consequences of ED exposure need to be investigated to elucidate the mechanisms underlying their adverse effects on the reproductive, neurological and immunological systems.
To understand the molecular mechanism(s) underlying the detrimental effects associated with the androgenicity and antiandrogenicity of EDs in this study, we examined the reproductive malformations and hypospermatogenesis of adult male rats after maternal exposure to TP, an environmental chemical with potent androgenicity, and DEHP or Flu, two well-known antiandrogenlike EDs, and determined the altered gene expression profiles in the rat fetal testis in response to the androgen and antiandrogens using a microarray approach. In addition, we also examined the effects of these EDs on androgen biosynthesis and signaling pathways to obtain a better understanding of the potential impact of EDs on the male reproductive system during the "critical window" of development in a rat model.
Materials and Methods

Chemicals
Testosterone propionate (TP, # 203-08433) and Di-(2-ethylhexyl) phthalate (DEHP, # 80032) were purchased from Wako Pure Chemical Industries (Japan). Flutamide (F-9397) and corn oil were obtained from Sigma Aldrich (St. Louis, MO, USA). These chemicals were selected for these experiments as potential EDs.
Animals and treatments
Female Sprague Dawley (SD; 8 weeks old) rats were purchased from Samtako Bio Korea (Gyeonggi, Republic of Korea). The rats were housed in polycarbonate cages in a controlled environment under an illumination schedule of 12 h light/12 h dark and were fed soy-free pellet food (Samyang, Korea), with water provided ad libitum. Female rats were mated with 10-week-old males during proestrus, and the day that evidence of vaginal plugs and/or sperm presence in vaginal smears was recognized was taken as gestation day 0 (GD 0). The Ethics Committee at the Chungbuk National University approved of all experimental procedures and animal use. From GD 11 to GD 21, pregnant rats (n=8) were given daily oral gavage with TP (1 mg/kg BW/day), DEHP (10, 100 and 500 mg/kg BW/day) or Flu (1, 10 and 50 mg/kg BW/day). One group of animals (n=8) received only corn oil (5 ml/kg BW/day) and served as the vehicle control. The changes in maternal body weights, clinical signs and/or abnormal behavior were recorded throughout the experimental period.
Experimental designs
Stage 1: Effects of maternal exposure to EDs on the male fetus at GD 21: On GD 21, four dams from each group were euthanized, and the male fetuses from each dam were counted and weighed. The testes of four fetuses were collected and fixed in Bouin's solution for immunohistochemical analysis. The other testes were used for RNA isolation (pooled samples).
Stage 2: Effects of maternal exposure to EDs on male offspring at PND 63: The adverse effects of EDs on male offspring were determined at different developmental stages. At PND 1, pups were counted, weighed and sexed. At PND 13, animals were examined for the presence or absence of areolae, the dark areas lacking hair found in the region of the developing nipple bud. Neonatal body weights were measured weekly, and rats were examined for abnormal clinical signs daily. The male rats were separated from their mothers at PND 22 (n=10) and were euthanized by inhalation of ethyl ether at PND 63. Anogenital distance (AGD), the distance between the center of the anus and the center of genital bud, was measured in a blind fashion using a ruler. The testes, epididymis and prostate were removed and weighed. In addition, testes were fixed in Bouin's solution, embedded in paraffin, sectioned at 5 μm and evaluated by immunohistochemistry.
Sperm analysis
In order to determine ED-induced effects on sperm quality, sperm from the right testis were collected through micropuncture of the caudal epididymis at PND 63 and diluted with semen diluting fluid. Sperm number was counted by the hemotocytometer method, and the motility and viability of sperm were also evaluated. Briefly, ten microliters of the diluted sperm suspension were loaded into a hemacytometer chamber. After 5-10 min in a humid chamber to allow the sperm to settle, the sperm were counted from the top row in the central large square of the hemacytometer grid. Counts were performed using 200× magnification, and only recognizable sperm, including loose heads, were calculated. Additionally, the motility and viability of sperm were also determined as described previously [17] .
Hormonal measurements
Blood was collected from male fetuses at GD 21 and offspring rats at PND 63, respectively. Serum was prepared immediately and stored at -20 C until required for serum hormone analysis. A commercially available ELISA kit was used to measure the serum concentration of testosterone and LH [ELISA (RE52151); INRA, France].
Total RNA preparation
The testes of male fetuses were excised rapidly and washed with sterile normal saline. Total RNA from pooled testes were extracted with Trizol (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol, and the concentration and quality of RNA were determined by the ratio of absorbance at 260/280 nm at which a high ratio of RNAs (over 2.0) would be accepted as pure RNAs. Two micrograms of total RNA were denatured by heating 85 C for 5 min and loaded onto a 1% agarose gel to confirm RNA quality.
Hybridization and cDNA microarray analysis
The Affymetrix GeneChip® Rat Genome 230 2.0 Array (Affymtrix, Santa Clara, CA, USA), containing over 31,000 probe sets and representing over 28,000 well-substantiated rat genes, was used for microarray experiments. All total RNA (5 μg) was diluted in RNase-free water (8 μl). Synthesis of cDNA, synthesis of biotin-labeled cRNA, fragmentation, hybridization, washing and scanning were all performed according to the manufacturer's protocols. The arrays were scanned in a GeneChip scanner 3000 (Affymetrix). Image processing and expression analysis were performed using the Affymetrix GeneChip Operating System (GCOS). The resultant cell intensity files (CEL) were subjected to statistical analysis and data normalization using GenePlex software version 2.0 (Istech, Korea) as previously described [18] . Logged gene expression ratios from the fluorescent intensity of each spot were normalized by LOWESS (locally weighted scatter plot smoother) regression. Statistical analysis was performed to evaluate global gene expression patterns using one-way ANOVA, and statistical significance was assigned at P<0.05. The differentially expressed genes were selected based on statistical significance and a minimum 3-fold change for at least one time point. The selected genes were analyzed by two-dimensional hierarchical clustering based on Pearson correlation and Complete Linkage. The biological pathways of genes were classified based on pathway analysis in which the classification of pathways in the interested genes was determined based on the Database for Annotation Visualization and Integrated Discovery (DAVID) (http://david.abcc.ncifcrf.gov/).
RealTime PCR analysis of gene expression
Microarray results were confirmed and validated by real-time PCR. A 7300 RealTime PCR System (Applied Biosystems, Foster, CA, USA) was used to perform relative quantification of mRNAs. The RT-PCR reaction product was analyzed in a 20-μl reaction volume containing 10 μl of SYBR premix Ex Taq (TaKaRa Bio., Seoul, Korea). The primers were designed using the Primer3 program (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi), and the primer sequences are described in Table 1 . This method followed an initial denaturation at 95 C for 5 min, followed by 40 cycles of denaturation at 95 C for 30 sec, annealing at 55-65 C for 30 sec, and extension at 72 C for 45 sec. The relative expression levels of these genes were normalized to HPRT1. The relative quantification of each mRNA was analyzed by the Comparative Ct Method (ΔΔCt) [19] .
Immunohistochemical analysis of AR expression
The localization of AR protein in the testis was detected by immunohistochemistry. The tissues were embedded in paraffin, sectioned at 5 μm, and mounted on slides. The sections were deparaffinized in xylene, hydrated in descending grades of ethanol and heated using a microwave oven in 2.3% citrate buffer (dilution in deionized water, pH 6.0) for antigen retrieval. Nonspecific interactions were prevented by incubation with 3% (w/v) bovine serum albumin dissolved in phosphate-buffered saline (PBS). The sections were incubated with the primary antibody (rabbit polyclonal antibody, #A207, Santa Cruz Biotechnology, Santa Cruz, CA, USA) overnight at 4 C. After incubation with the primary antibody, the slides were washed in PBS-Tween-20, incubated with the secondary antibody (goat anti-rabbit IgG, #H3107; 1:250) and then incubated with the avidin-biotin peroxidase for 30 min at 37 C. The sections were then treated with liquid diaminobenzidine (2 tablets in 5 ml distilled water; Sigma Fast TM 3,3-diaminobenzidine; Sigma-Aldrich Biotech, St. Louis, MO, USA), washed in water, counterstained with hematoxylin and mounted with paramount.
Statistical analyses
Organ weights were analyzed as covariate with body weight at necropsy. The data are presented as means ± SD and analyzed by one-way analysis of variance (ANOVA).When a statistically significant effect of a treatment was detected, Tukey's test (control versus treatment group; significance value of P<0.05) was used to compare the results in the treatments. 
Results
Effects of EDs on steroid hormones
Serum testosterone and LH concentrations were analyzed by ELISA in male fetuses at GD 21 and offspring rats at PND 63. The serum levels of testosterone and LH in male neonates following maternal DEHP treatment gradually decreased in a dose-dependent manner. However, only a high dose (500 mg/kg BW/day) of DEHP caused a significant decrease compared with the control group (P<0.01). Conversely, both the testosterone and LH levels evoked by maternal Flu exposure were increased in a dose-dependent manner, particularly for the highest Flu dose (50 mg/kg BW/ day; P<0.001), as shown for male fetuses at GD 21 in Table 2 . No significant differences in the LH and testosterone concentrations were noted in male offspring at PND 63 compared with the control group (Table 3) .
Reproductive tract malformation
All malformations of the external genitalia and changes of internal reproductive tracts were noted in male offspring. The AGD values of male offspring at PND 63 were significantly decreased in the groups exposed in utero to the intermediate dose of DEHP (100 mg/kg BW/day) and all Flu-treated groups, compared with the control group (P<0.001) as shown in Table 3 . At PND 13, an abnormal number of nipples or areolae was found in all Flu-treated groups and following maternal exposure to DEHP (500 mg/kg BW/day) compared with the control group (P<0.001). Specifically, the number of nipples and/or areolae significantly increased in response to all doses of Flu, whereas only treatment with a high dose of DEHP induced an increase in the number of nipples, as shown in Table 3 . Interestingly, some nipples and/or areolae disappeared at PND 63 (data not shown). The weights of reproductive organs, including testes and epididymes, were significantly decreased in the rats prenatally exposed to Flu (50 mg/kg BW/day), as indicated in Table 3 . Also, the prostate weights were affected by the Flu treatment. Interestingly, all ventral and dorsolateral prostates of male offspring were undetectable following maternal exposure to a high dose of Flu (Table 3) .
The effects of EDs on reproductive tract malformation were determined by histopathological methods. As shown in Table 3 , hypospadias were observed in all male rats exposed to DEHP (500 mg/kg BW/day) or Flu (10 and 50 mg/kg BW/day). Additionally, cryoptorchidism was markedly increased in response to maternal DEHP exposure (500 mg/kg), with 17.4% of male rats exhibiting undescended testes (both uni-and bilateral). In the Flu-treated groups, cryoptorchidism was increased in a dose-dependent manner, with 11.11% of male rats displaying unilateral cryoptorchidism following maternal exposure to 10 mg/kg BW of Flu. Bilateral cryoptorchidism was observed in all male rats exposed to the 50 mg/kg BW/day Flu treatment ( Table 3 ). The descending time and place of the testes in the scrotum were also examined. However, no significant differences were observed compared with the control group, except for the group exposed to the highest levels of DEHP (500 mg/kg BW/day).
Sperm morphology and quality
The changes in sperm quality were also examined following maternal exposure to EDs, as described in the Materials and Methods. Exposure to TP caused a modest increase in sperm concentration, viability and motility percentages compared with all the treated groups. These parameters were significantly decreased (P<0.001) following exposure to DEHP (10 mg and 500 mg/kg BW/day) or Flu (1 and 10 mg/kg BW/day), as compared with vehicle, and no sperm were observed in the high dose group (50 mg/kg BW/day) of Flu treatment, as indicated in Table 3 .
Immunohistochemistry
In order to examine the localization of androgen receptor (AR) proteins in the fetal testis following DEHP and Flu treatment, immunohistochemistry was performed as described in Materials and Methods. AR proteins were located in the interstitial cells, peritubular myoid cells and undifferentiated epithelial cells. A few or no stained cells were detected following maternal DEHP treatment, whereas large numbers of cells that stained positive for AR proteins were observed in the Flu-treated groups, as shown in Fig. 1 , indicating their different effects on the developing male reproductive organs.
Gene expression patterns in fetal testes
Alterations in gene expression profiles evoked by ED exposure during pregnancy were further determined by using a cDNA microarray. The altered genes were selected because of their direct or indirect involvement with physiological processes including signal transduction, transcription, lipid metabolic, steroid metabolic, and androgenic-and estrogenic-related processes, and sex determination-related genes and are listed in Table 4 (a-d). In addition, some marker genes were also selected, as indicated in Table 5 . These marker genes were used to confirm the microarray data by using real-time PCR. The gene expression levels as determined by real-time PCR are shown in Fig. 2 (A-D) .
Because the serum concentration levels of testosterone were altered by these EDs, we hypothesized that steroidogenesis-related genes would be affected by ED exposure. Indeed, our results demonstrated that the steroidogenic acute regulatory protein (StAR), a protein involved in the transfer of cholesterol from the cytosol to the outer mitochondrial membrane, and cytochrome P450 (Cyp11a1, as P450scc) were significantly reduced at GD 21 in response to DEHP or Flu compared with the control. Furthermore, a significant decrease in 3-beta-hydroxysteroid dehydrogenase type 1 (HSD3b1) mRNA expression in the DEHP-treated (10 and 100 mg/kg BW/day) and all Flu-treated groups was noted. However, treatment with the highest dose of DEHP significantly increased its transcriptional level ( Fig. 2A) .
Of the 16,384 genes spotted on microarray chips, the expressions of 1,389 genes were altered by DEHP (100 and 500 mg/kg BW/day) and Flu (10 and 50 mg/kg BW/day) treatment compared with treatment with vehicle alone. Among them, 429 genes were upregulated and 960 genes were downregulated by in utero exposure to DEPH or Flu. One of the sex determination-related genes down-regulated by DEHP or Flu, as compared with TP, was cytochrome P450 (Cyp19a1; Table 4-d). It was of interest that hydroxysteroid (17-beta) dehydrogenase 3 (Hsd17b3) was not remarkably affected by either treatment, but that short stature homeobox 2 gene (Shox 2) expression was up-regulated by the highest dose of DEHP or Flu. The LIM homeobox protein 1 (Lxh1) Fig. 1 . Localization of AR protein in the fetal testis following exposure to TP, (1 mg/kg BW/day), DEHP (10, 100, 500 mg/kg BW/day) and Flu (1, 10, 50 mg/kg BW/day). Testis slides were stained with an antiandrogen receptor antibody as described in Materials and Methods. AR proteins were located in the interstitial cells, peritubular myoid cells and undifferentiated epithelial cells (arrows). Low expression levels of AR proteins were detected by DEHP in a dose-dependent manner, whereas an abundance of this protein was observed in the Flu-treated groups.
gene was also markedly downregulated by DEHP (500 mg/kg BW/ day), as shown in Table 4 -d. Genes involved in the steroid metabolic process were also examined. Among a total of 7 genes, Cyp11b1, Cyp11b2 and Nr1h4 were upregulated, but Pon1 was down-regulated by DEHP or Flu, as compared with vehicle. Interestingly, Cyp11b2 mRNA was increased up to 10-fold by a high dose (50 mg/kg BW/day) of Flu compared with the control. In contrast, Pon1 was reduced approximately 12-fold by DEHP (100 mg/kg BW/day), as demonstrated in Table 4 -c. In addition, steroid 5 alpha-reductase 1 (Srd5a1) gene expression was not dramatically changed in relation to vehicle (Table 4-c). In the estrogen signaling pathway, estrogen receptor 2 beta (Esr2) gene expression was up-regulated by all treatments of Flu (10 and 50 mg/kg BW/ day), and its gene expression was altered by 5 and 10-fold changes, respectively, as shown in Table  4 -c.
Seven genes were selected from our microarray data that may serve as markers to screen for the dose-dependent effects of TP, DEHP or Flu exposure in fetal testes, as seen in Figs. 2B-D and Table 5 . These include three marker genes for TP, casein kinase 2, alpha 1 polypeptide (Csnk2a1), large subunit GTPase 1 homolog (Lsg1) and pyridoxine 5'-phosphate oxidase (Pnpo). There were two marker genes for DEHP, stanniocalcin 1 (Stc1) and a gene similar to ankyrin repeat domain 6 (Ard6). In addition, two genes were markers for Flu, actin alpha cardiac 1 (Actc1) and cysteine rich protein 61 (Cyr61). 
Discussion
In this study, we demonstrated that maternal exposure to DEHP and Flu results in some striking differences in a number of phenotypes. Specifically, we demonstrate that male offspring exposed in utero to DEHP and Flu exhibit very different steroid hormone levels, have significant differences in AR protein expression levels in the testis and show differential gene expression patterns in RNA isolated from testes.
A measurement of AGD is considered to be a bioassay for fetal androgen action [20] . Alterations in AGD in early postnatal life were not only observed in male rats exposed to the different doses (100 mg/kg BW/day) of DEHP, but also in all the Flu-treated groups. Previously, it has been shown that a significant reduction of AGD in adult male offspring is induced by maternal exposure to high doses (405 and 500 mg/kg/day) of DEHP during lactation [21] . In addition, a decline evoked by this phthalate in testosterone synthesis results in decrease in the AGD value. A recent study has indicated that exposure to Flu [22] reduces AGD in PND-4 and PND-60 rats. Also, exposure to this AR antagonist from GD 12 to 21 results in permanent alterations in AGD [23] . Although it is well known that Flu may act partly by anti-androgen-mimicking mechanisms, the mode of DEHP actions in androgen-responsive tissues remains to be elucidated. Nipple retention appears to be a useful maker for identifying reproductive tract lesions in response to antiandrogens [6] . In addition, this phenotype is associated with other adverse changes in DHT-mediated processes such as genital malformations [24] . These observations confirm and extend the previous findings that Flu preferentially alters DHT-mediated growth. In this study, in utero exposure to DEHP and Flu caused an increase in the number of nipples and /or areolae in a dose-dependent manner. Our results are in agreement with the previous reports [22, 25] . We demonstrated in this study that DEHP and Flu interfered with the development of reproductive organs in a dose-dependent manner, in agreement with previous reports [12, 26] . A decrease in the testicular, epididymal and prostate weights was caused by in utero Flu exposure. In addition, malformation of the external genitalia was observed in groups exposed to all doses of Flu. One significant clinical observation was that of undescended testes, observed in four male rats exposed to a high dose (500 mg/kg BW/ day) of DEHP. Particularly, the undescended testes were located in the super-inguinal position and undetectable, and atrophied gubernaculums were also noted in response to Flu, suggesting that the inhibiting effects of Flu treatment occurred in a dose-dependent manner in the transinguinal phase [27] . Similarly, exposure to the anti-steroidogenic effect of a high dose of DEHP or Flu caused developmental disorders, i.e., hypospadias and cryptorchidism, in all male offspring [28, 29] . Thus, the short-term blockade of androgen action by the antiandrogen-mimicking activities of EDs during a critical period of pregnancy caused cryptorchidism with a high frequency.
It is clear that the expression of the AR is detectable at an early stage in the rat fetal testis, at gestation day 14-15 [7] . Based on our results, AR proteins are located in the interstitial cells, peritubular myoid cells and undifferentiated epithelial cells. A few or no stained cells were detected by DEHP treatment, whereas an abundance of cells that stained positive for this protein was observed in the Flu-treated group. Previous studies have indicated that AR plays an important role in Flu-mediated response, while phthalates including DEHP do not interact with AR at a physiological concentration [8, 30] . Moreover, DEHP is thought to activate PPAR, leading to downregulation of SR-B1 and PBR or effects on SF-1 that consequently regulate steroidogenesis-related genes [31] .
The serum hormone levels of LH and testosterone were evaluated in our study. The testosterone and LH levels in the male neonates following maternal DEHP treatment gradually decreased in a dose-dependent manner, while a significant increase in testosterone levels was evoked by Flu. Several previous studies have reported that Flu blocks the physiological action of testosterone at androgenic receptor sites and/or alters androgen receptor levels [32] and, consequently, causes atrophic changes to the seminiferous tubules by depressing the function of Sertoli cells. In contrast, the testicular toxicity of DEHP negatively affects Sertoli and germ cells [33] , disrupts Leydig cells [30] and impairs Sertoli cell proliferation [33] , suggesting that the mechanism of action of DEHP involves the downregulation of testosterone levels.
The alteration in the gene expression pattern following treatment with EDs was previously investigated in rats [34] in which many testicular genes related to intracellular signaling, cellular interactions and gene transcription were dysregulated by phthalate exposure. In order to understand the mechanism(s) underlying the molecular events evoked by these EDs, we used cDNA microarray technology to determine altered gene expression patterns in the fetal testes. These altered genes are involved in sex determination, steroid metabolism, and lipid homeostasis. It has been reported that a significant decrease in the expression of cytochrome P450 (Cyp19a1) gene, a member of the family of sex determinationrelated genes, is observed when fetal testes are maternally exposed to DBP [35] . In addition, DBP and DEHP have similar modes of action in development of the male reproductive tract by which they exert their effects on the regulation of gene expression involved in cholesterol transport and testosterone synthesis [36] . In the present study, this gene was downregulated by DEHP and Flu. The hydroxysteroid 17-beta dehydrogenase 3 (Hsd17b3) was also affected by both DEHP and Flu treatment. Induction of rat HSD 17β protein expression was observed in a time-and dose-dependent fashion following di-n-butyl phthalate treatment in previous studies, indicating that this gene plays a special role in cholesterol metabolism and suggesting that it is a peroxisome proliferator-activated gene as described previously [37] .
In addition, the antiandrogenic activities of DEHP and Flu in the developing male reproductive system have been shown to elicit different effects on sex steroid gene expression patterns. Cytochrome P450scc (Cyp11a1), a monooxygenase, is necessary for the synthesis of cholesterol and steroids, and a decrease in the expression level of Cyp11a1 following DEHP and/or Flu exposure was identified in the present study, in agreement with previous demonstrations [36, 38] . During the critical stages of sexual differentiation, treatment with DEHP and/or Flu induced significant downregulation of steroid biosynthesis and metabolism-related genes, such as 3beta-steroid delta isomerase (Hsd3b1) and steroidogenic acute regulatory protein (StAR). It has been reported that the short-term and long-lasting effects of DEHP on testicular steroidogenesis are distinct in fetal and adult Leydig cells, and a decrease in the expression levels of steroidogenesis-regulated genes following exposure to this ED exposure is anticipated [38] .
As expected, in our present study, a reduction in the expression of testicular steroidogenesis-related factor StAR was observed. These findings support a theory in which a decrease in testosterone pro- duction and/or steroidogenesis-related genes may be evoked by in utero DEHP or Flu exposure. Previous studies have suggested that a variety of genes involved in the development of steroidogenic organs appear to be regulated by nuclear transcription factor (SF-1) and PPAR. A decline in the expressions of Cyp11a1, StAR and/or Hsd3b1 in response to DEHP [31] or flu [39] via an SF-1 and PPAR-mediated mechanism(s) has previously been shown. The expression of other genes involved in steroid metabolic processes was also examined; DEHP and Flu up-regulated the expression of Cyp11b1, Cyp11b2 and/or Nr1h4, whereas a down-regulation in Pon1 expression was induced by these chemicals. Identification of a set of marker genes is very important for classifying the androgenic and/or antiandrogenic activities of EDs during certain crucial windows of development. In the current study, we also identified genes that we classified as markers for TP, DEHP or Flu. Casein kinase 2 alpha 1 polypeptide (Csnk2a1) appears to be a protein serine kinase that plays a role in regulation of cell growth and proliferation, and large subunit GTPase 1 homolog (S. cerevisiae; Lsg1) is a member of a GTPase family that participates in a wide range of cellular processes. The expression levels of Csnk2a1 and Lsg1 were markedly induced by TP, whereas expression of the pyridioxine 5'-phosphate oxidase (Pnpo) gene, the rate limiting enzyme in pyridoxal 5-phosphate biosynthesis in the rat, was significantly decreased by TP in this study. Marker genes for DEHP exposure were also identified in our study. For instance, the expression level of the stanniocalcin 1 (Stc1) gene was upregulated (2-to 3-fold) following DEHP treatment, while a gene similar to ankyrin repeat domain 6 (Ard6) showed significant downregulation. It has been reported that Stc1, an important gene in the process of stimulating osteoblast differentiation, is considered to be a pleiotropic factor in mammals [40] . In addition, induction of Stc1 expression by dexamethasone (DEX, 100 nM) has been observed in a rat primary Sertoli cell culture, suggesting that it responds to environmental chemicals in the male reproductive system [41] . Ard6 gene is essential for many cellular process, such as cell fate determination, endocytosis, transcriptional regulation and cell cycle control [42] . In the current study, treatment with DEHP caused strong downregulation in the expression level of this gene, as shown in Fig. 2C . Based upon our microarray data, both the alpha-actin cardiac 1 (Actc1) and cysteine rich protein 61 (Cyr61) genes exhibited the highest response to Flu treatment and could serve as a set of markers for Flu effects in the developing male reproductive tract. The Actc1 gene may act as a structural component of the cytoskeleton or play a role in muscle function. In a previous study, administration of Flu (25 mg/kg BW/day) affected cardiovascular function, resulting in an increase in cardiac testosterone and/or aromatase activity by blocking the androgen receptor after trauma hemorrhage [43] . Our findings also indicated an upregulation, from 3-to 5-fold, of Actc1 gene expression in response to Flu (10 and 50 mg/kg BW/day), compared with the control. Additionally, Cyr61 is well known as a growth factorinducible immediate early gene in fibroblasts [44] that plays a critical role in the promotion of proliferation, migration and adhesion of endothelial cells and fibroblasts [45] and affects angiogenesis and tumor growth [46] . Cyr61 levels were significantly decreased following the high-dose Flu treatment in this study. Although the functions of these genes have been reported, a series of further experiments are required to explain the molecular mechanism(s) underlying the events in which EDs exert effects on the modulation and regulation of these "biomarker genes" in the reproductive system.
In summary, we conclude that although Flu and DEHP are considered to be identical antiandrogenic chemicals, their effects on the developing male reproductive organs appear to be distinct. Flu may compete with endogenous T, while DEHP could influence a different step of androgenesis. Taken together, these findings may provide new insight into the modes of antiandrogenic ED actions in developing reproductive systems and help to predict adverse consequences of EDs.
